Lantheus Holdings, Inc. (LNTH)
USD 102.13
(0.13%)
USD 102.13
(0.13%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.29 Billion USD | 38.65% |
| 2022 | 935.06 Million USD | 119.91% |
| 2021 | 425.2 Million USD | 25.28% |
| 2020 | 339.41 Million USD | -2.28% |
| 2019 | 347.33 Million USD | 1.15% |
| 2018 | 343.37 Million USD | 3.62% |
| 2017 | 331.37 Million USD | 9.78% |
| 2016 | 301.85 Million USD | 2.86% |
| 2015 | 293.46 Million USD | -2.7% |
| 2014 | 301.6 Million USD | 6.32% |
| 2013 | 283.67 Million USD | -1.54% |
| 2012 | 288.1 Million USD | -19.14% |
| 2011 | 356.29 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 394.09 Million USD | 6.52% |
| 2024 Q1 | 369.97 Million USD | 4.51% |
| 2023 Q2 | 321.7 Million USD | 6.95% |
| 2023 Q1 | 300.78 Million USD | 14.29% |
| 2023 FY | 1.29 Billion USD | 38.65% |
| 2023 Q4 | 353.99 Million USD | 10.64% |
| 2023 Q3 | 319.94 Million USD | -0.55% |
| 2022 Q4 | 263.16 Million USD | 9.98% |
| 2022 Q1 | 208.88 Million USD | 61.22% |
| 2022 Q2 | 223.72 Million USD | 7.11% |
| 2022 Q3 | 239.29 Million USD | 6.96% |
| 2022 FY | 935.06 Million USD | 119.91% |
| 2021 FY | 425.2 Million USD | 25.28% |
| 2021 Q1 | 92.5 Million USD | -1.75% |
| 2021 Q3 | 102.07 Million USD | 1.0% |
| 2021 Q4 | 129.56 Million USD | 26.93% |
| 2021 Q2 | 101.06 Million USD | 9.25% |
| 2020 Q4 | 94.15 Million USD | 6.33% |
| 2020 Q3 | 88.54 Million USD | 34.14% |
| 2020 FY | 339.41 Million USD | -2.28% |
| 2020 Q2 | 66.01 Million USD | -27.22% |
| 2020 Q1 | 90.7 Million USD | 1.52% |
| 2019 Q4 | 89.34 Million USD | 4.16% |
| 2019 Q1 | 86.51 Million USD | 0.28% |
| 2019 Q2 | 85.7 Million USD | -0.93% |
| 2019 FY | 347.33 Million USD | 1.15% |
| 2019 Q3 | 85.77 Million USD | 0.08% |
| 2018 Q2 | 85.57 Million USD | 3.56% |
| 2018 FY | 343.37 Million USD | 3.62% |
| 2018 Q1 | 82.63 Million USD | 1.71% |
| 2018 Q4 | 86.27 Million USD | -2.96% |
| 2018 Q3 | 88.9 Million USD | 3.89% |
| 2017 FY | 331.37 Million USD | 9.78% |
| 2017 Q3 | 79.94 Million USD | -10.01% |
| 2017 Q2 | 88.83 Million USD | 9.19% |
| 2017 Q1 | 81.35 Million USD | 9.43% |
| 2017 Q4 | 81.24 Million USD | 1.63% |
| 2016 Q2 | 77.96 Million USD | 1.95% |
| 2016 FY | 301.85 Million USD | 2.86% |
| 2016 Q4 | 74.35 Million USD | 1.76% |
| 2016 Q1 | 76.47 Million USD | 7.41% |
| 2016 Q3 | 73.06 Million USD | -6.29% |
| 2015 Q2 | 73.31 Million USD | -2.02% |
| 2015 Q1 | 74.82 Million USD | -2.79% |
| 2015 Q3 | 74.12 Million USD | 1.1% |
| 2015 FY | 293.46 Million USD | -2.7% |
| 2015 Q4 | 71.2 Million USD | -3.94% |
| 2014 Q2 | 75.61 Million USD | 3.1% |
| 2014 FY | 301.6 Million USD | 6.32% |
| 2014 Q4 | 76.96 Million USD | 1.7% |
| 2014 Q3 | 75.68 Million USD | 0.09% |
| 2014 Q1 | 73.33 Million USD | 2.33% |
| 2013 FY | 283.67 Million USD | -1.54% |
| 2013 Q1 | 71.01 Million USD | -1.7% |
| 2013 Q2 | 70.6 Million USD | -0.59% |
| 2013 Q3 | 70.38 Million USD | -0.31% |
| 2013 Q4 | 71.66 Million USD | 1.82% |
| 2012 FY | 288.1 Million USD | -19.14% |
| 2012 Q4 | 72.24 Million USD | 0.0% |
| 2011 FY | 356.29 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | -128.741% |
| Embecta Corp. | 1.12 Billion USD | -15.67% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | -166.308% |
| Dynavax Technologies Corporation | 232.28 Million USD | -458.122% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | -1014.402% |
| Pacira BioSciences, Inc. | 674.97 Million USD | -92.07% |
| PainReform Ltd. | - USD | -Infinity% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | -2462.974% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -5280.984% |
| SCYNEXIS, Inc. | 140.14 Million USD | -825.089% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -67124.839% |
| Cosmos Health Inc. | 53.37 Million USD | -2328.822% |
| Journey Medical Corporation | 79.18 Million USD | -1537.298% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -5280.984% |
| Safety Shot Inc | 202.67 Thousand USD | -639574.841% |
| Alpha Teknova, Inc. | 36.68 Million USD | -3434.045% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | -179.18% |
| Bright Green Corporation | 401.49 Thousand USD | -322803.627% |
| Procaps Group, S.A. | 409.92 Million USD | -216.264% |
| Theratechnologies Inc. | 81.76 Million USD | -1485.574% |
| Harrow Health, Inc. | 130.19 Million USD | -895.775% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -10080.047% |
| Biofrontera Inc. | 34.07 Million USD | -3705.081% |
| DURECT Corporation | 8.54 Million USD | -15066.46% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | -113.397% |
| Cronos Group Inc. | 88.84 Million USD | -1359.271% |
| OptiNose, Inc. | 70.98 Million USD | -1726.291% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | -192.823% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -19804.722% |
| Organogenesis Holdings Inc. | 433.14 Million USD | -199.309% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -10484.347% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | -3177.742% |
| Radius Health, Inc. | 2.88 Billion USD | 55.02% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -3912.627% |
| ProPhase Labs, Inc. | 44.38 Million USD | -2820.938% |
| Phibro Animal Health Corporation | 1.01 Billion USD | -27.391% |
| Procaps Group S.A. | 409.92 Million USD | -216.264% |
| Alvotech | 91.43 Million USD | -1317.885% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -99472.12% |
| Viatris Inc. | 15.42 Billion USD | 91.596% |
| Rockwell Medical, Inc. | 83.61 Million USD | -1450.53% |
| Aytu BioPharma, Inc. | 81 Million USD | -1500.49% |
| SIGA Technologies, Inc. | 139.91 Million USD | -826.569% |
| Tilray Brands, Inc. | 788.94 Million USD | -64.325% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | -910.774% |
| Shineco, Inc. | 9.8 Million USD | -13126.362% |
| PetIQ, Inc. | 1.1 Billion USD | -17.647% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -10803475.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 31.3% |
| Alimera Sciences, Inc. | 80.75 Million USD | -1505.405% |
| Silver Spike Investment Corp. | 11.72 Million USD | -10959.668% |
| Assertio Holdings, Inc. | 152.06 Million USD | -752.527% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -22166.276% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -7343.469% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -120340.633% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -4536.23% |
| Hempacco Co., Inc. | 4.04 Million USD | -31945.114% |
| Talphera, Inc. | 651 Thousand USD | -199044.24% |
| Alvotech | 91.43 Million USD | -1317.885% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | -309.472% |
| Currenc Group, Inc. | 53.25 Million USD | -2334.363% |
| Kamada Ltd. | 144.75 Million USD | -795.579% |
| Indivior PLC | 1.09 Billion USD | -18.612% |
| Evoke Pharma, Inc. | 5.18 Million USD | -24924.543% |
| Flora Growth Corp. | 76.07 Million USD | -1604.236% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -120340.633% |
| Evolus, Inc. | 202.08 Million USD | -541.527% |
| HUTCHMED (China) Limited | 837.99 Million USD | -54.705% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | -101.185% |
| Akanda Corp. | 2.16 Million USD | -59918.416% |